Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lobo

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
JAMA Cardiology|February 28, 2023
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO TrialsAjay J Kirtane, Andrew S P Sharp, Felix Mahfoud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2025
Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph diseaseCarina Henriques, Patrícia Albuquerque, David Rufino-Ramos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 24, 2016
Renal denervation in hypertensive patients not on blood pressure lowering drugsRosa L De Jager, Margreet F Sanders, Michiel L Bots, et al.
European Heart Journal|May 6, 2017
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the futureFelix Mahfoud, Roland E Schmieder, Michel Azizi, et al.
European Heart Journal|May 21, 2015
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial designFelix Mahfoud, Michael Böhm, Michel Azizi, et al.
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Circulation|March 14, 2022
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research ConsortiumDavid E Kandzari, Felix Mahfoud, Michael A Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
JAMA Cardiology|February 28, 2023
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO TrialsAjay J Kirtane, Andrew S P Sharp, Felix Mahfoud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2025
Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph diseaseCarina Henriques, Patrícia Albuquerque, David Rufino-Ramos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 24, 2016
Renal denervation in hypertensive patients not on blood pressure lowering drugsRosa L De Jager, Margreet F Sanders, Michiel L Bots, et al.
European Heart Journal|May 6, 2017
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the futureFelix Mahfoud, Roland E Schmieder, Michel Azizi, et al.
European Heart Journal|May 21, 2015
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial designFelix Mahfoud, Michael Böhm, Michel Azizi, et al.
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Circulation|March 14, 2022
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research ConsortiumDavid E Kandzari, Felix Mahfoud, Michael A Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
Pageof 20